March 25, 2011
/PRNewswire/ -- Tibet Pharmaceuticals, Inc. (Nasdaq: TBET), an emerging specialty pharmaceutical company engaged in the development, manufacturing and marketing of traditional Tibetan medicine in
, will host a conference call on
Friday, April 1, 2011
Eastern to discuss its fiscal year-end
December 31, 2010
financial results. Tibet's 10-K and corresponding earnings release is expected to be filed on
March 30, 2011
"At Tibet Pharmaceuticals' first conference call since becoming a publicly listed NASDAQ company, we look forward to updating our shareholders on our financial results and recent developments," said
, Chief Executive Officer of Tibet Pharmaceuticals. "Tibet has consistently delivered strong revenue and earnings growth year over year, and we believe this trend is set to continue for fiscal 2011 and beyond."
The teleconference can be accessed by dialing 877-407-0778 when calling within
the United States
or 201-689-8565 when calling internationally. Please dial in 10 minutes prior to the beginning of the call. There will be a playback available until
June 14, 2011
. To listen to the playback dial 877-660-6853 when calling within
the United States
, or 201-612-7415 when calling internationally and use account number: 286, in conjunction with replay ID number: 369954.
The conference call will be simultaneously webcast and available on the company's website,
, under the "Events and Presentations" tab of the "Investors" section.
About Tibet Pharmaceuticals, Inc.
Based in Shangri-La County,
, Tibet Pharmaceuticals, Inc. (NASDAQ: TBET) is a is a rapidly growing specialty pharmaceutical company engaged in the research, development, manufacturing and marketing of modernized traditional Tibetan medicines in
. With over 190 full-time employees and national-wide distributors, the Company develops both prescription and over-the-counter ("OTC") traditional Tibetan medicines that promote health in human respiratory, digestive, urinary and reproductive systems. Tibet Pharmaceuticals' products are sold throughout
, with a majority of sales concentrated in the southern provinces, most notably the
, where the Company's 52,000 sq. ft. fully GMP-certified manufacturing facilities are located. The access to key raw materials is not generally available outside the province and provides a significant advantage for Tibet Pharmaceuticals.
For more information on Tibet Pharmaceuticals, please visit: